Literature DB >> 12773353

Validation of race/ethnicity and transmission mode in the US HIV/AIDS reporting system.

Lisa M Lee1, J Stan Lehman, Andrew B Bindman, Patricia L Fleming.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12773353      PMCID: PMC1447868          DOI: 10.2105/ajph.93.6.914

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  9 in total

1.  How inconsistencies in racial classification demystify the race construct in public health statistics.

Authors:  J S Kaufman
Journal:  Epidemiology       Date:  1999-03       Impact factor: 4.822

2.  Estimation of completeness of AIDS case reporting in Massachusetts.

Authors:  M M Jara; K M Gallagher; S Schieman
Journal:  Epidemiology       Date:  2000-03       Impact factor: 4.822

3.  Guidelines for national human immunodeficiency virus case surveillance, including monitoring for human immunodeficiency virus infection and acquired immunodeficiency syndrome. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1999-12-10

4.  Index for rating diagnostic tests.

Authors:  W J YOUDEN
Journal:  Cancer       Date:  1950-01       Impact factor: 6.860

5.  The completeness, validity, and timeliness of AIDS surveillance data.

Authors:  R M Klevens; P L Fleming; J Li; C G Gaines; K Gallagher; S Schwarcz; J M Karon; J W Ward
Journal:  Ann Epidemiol       Date:  2001-10       Impact factor: 3.797

6.  Cardiovascular diseases and risk factors in a population-based study in The Netherlands: agreement between questionnaire information and medical records.

Authors:  O H Klungel; A de Boer; A H Paes; J C Seidell; A Bakker
Journal:  Neth J Med       Date:  1999-10       Impact factor: 1.422

7.  Is there really a heterosexual AIDS epidemic in the United States? Findings from a multisite validation study, 1992-1995. Mode of Transmission Validation Study Group.

Authors:  R M Klevens; P L Fleming; J J Neal; J Li
Journal:  Am J Epidemiol       Date:  1999-01-01       Impact factor: 4.897

8.  Multistate evaluation of anonymous HIV testing and access to medical care. Multistate Evaluation of Surveillance of HIV (MESH) Study Group.

Authors:  A B Bindman; D Osmond; F M Hecht; J S Lehman; K Vranizan; D Keane; A Reingold
Journal:  JAMA       Date:  1998-10-28       Impact factor: 56.272

9.  The completeness of AIDS surveillance.

Authors:  J W Buehler; R L Berkelman; J K Stehr-Green
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992
  9 in total
  5 in total

1.  Date of first positive HIV test: reliability of information collected for HIV/AIDS surveillance in the United States.

Authors:  H Irene Hall; Jianmin Li; Michael Campsmith; Patricia Sweeny; Lisa M Lee
Journal:  Public Health Rep       Date:  2005 Jan-Feb       Impact factor: 2.792

2.  Characteristics of persons with heterosexually acquired HIV infection, United States 1999-2004.

Authors:  Lorena Espinoza; H Irene Hall; Felicia Hardnett; Richard M Selik; Qiang Ling; Lisa M Lee
Journal:  Am J Public Health       Date:  2006-11-30       Impact factor: 9.308

3.  The implications of respondent concurrency on sex partner risk in a national, web-based study of men who have sex with men in the United States.

Authors:  Eli S Rosenberg; Richard B Rothenberg; David G Kleinbaum; Rob B Stephenson; Patrick S Sullivan
Journal:  J Acquir Immune Defic Syndr       Date:  2013-08-01       Impact factor: 3.731

4.  Racial misidentification of American Indians/Alaska Natives in the HIV/AIDS Reporting Systems of five states and one urban health jurisdiction, U.S., 1984-2002.

Authors:  Jeanne Bertolli; Lisa M Lee; Patrick S Sullivan
Journal:  Public Health Rep       Date:  2007 May-Jun       Impact factor: 2.792

5.  Accuracy of routinely recorded ethnic group information compared with self-reported ethnicity: evidence from the English Cancer Patient Experience survey.

Authors:  C L Saunders; G A Abel; A El Turabi; F Ahmed; G Lyratzopoulos
Journal:  BMJ Open       Date:  2013-06-28       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.